{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:11:02Z","timestamp":1776082262326,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.japh.2025.103009","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T05:57:30Z","timestamp":1766123850000},"page":"103009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Methemoglobinemia induced by dapsone, hydroxychloroquine, and rifampin combination for post-treatment Lyme disease syndrome: A case report"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5205-693X","authenticated-orcid":false,"given":"Jarett","family":"Worden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler","family":"Baumeister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Stogner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6896-6780","authenticated-orcid":false,"given":"Nancy","family":"Henin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6807-5100","authenticated-orcid":false,"given":"Rebecca A.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.japh.2025.103009_bib1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/jamainternmed.2013.75","article-title":"Risk of topical anesthetic\u2013induced methemoglobinemia: a 10-year retrospective case-control study","volume":"173","author":"Chowdhary","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"15","key":"10.1016\/j.japh.2025.103009_bib2","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/cncr.25904","article-title":"Dapsone-induced methemoglobinemia: a dose-related occurrence?","volume":"117","author":"Esbenshade","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.japh.2025.103009_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.toxrep.2024.03.004","article-title":"Causes of acquired methemoglobinemia \u2013 a retrospective study at a large academic hospital","volume":"12","author":"Belzer","year":"2024","journal-title":"Toxicol Rep"},{"issue":"1","key":"10.1016\/j.japh.2025.103009_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11136-012-0126-6","article-title":"Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?","volume":"22","author":"Aucott","year":"2013","journal-title":"Qual Life Res"},{"issue":"14","key":"10.1016\/j.japh.2025.103009_bib5","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMra072023","article-title":"A critical appraisal of \u201cchronic Lyme disease.\u201d","volume":"357","author":"Feder","year":"2007","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.japh.2025.103009_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16293","article-title":"Treatment of post-treatment Lyme disease symptoms\u2014a systematic review","volume":"31","author":"Dersch","year":"2024","journal-title":"Euro J Neurol"},{"issue":"1","key":"10.1016\/j.japh.2025.103009_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa1215","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease","volume":"72","author":"Lantos","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.japh.2025.103009_bib8","series-title":"Statpearls","article-title":"Methemoglobinemia","author":"Ludlow","year":"2023"},{"issue":"12","key":"10.1016\/j.japh.2025.103009_bib9","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/ajh.26340","article-title":"Recommendations for diagnosis and treatment of methemoglobinemia","volume":"96","author":"Iolascon","year":"2021","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.japh.2025.103009_bib10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1345\/aph.1Q139","article-title":"Dapsone-induced methemoglobinemia: a primer for clinicians","volume":"45","author":"Barclay","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"8","key":"10.1016\/j.japh.2025.103009_bib11","doi-asserted-by":"crossref","first-page":"E196","DOI":"10.1002\/ajh.25868","article-title":"The emergence of methemoglobinemia amidst the COVID-19 pandemic","volume":"95","author":"Naymagon","year":"2020","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.japh.2025.103009_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006682","article-title":"Chlorproguanil\u2212dapsone\u2212artesunate versus artemether\u2212lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated plasmodium falciparum malaria","volume":"4","author":"Premji","year":"2009","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.japh.2025.103009_bib13","doi-asserted-by":"crossref","first-page":"969","DOI":"10.4269\/ajtmh.2009.09-0351","article-title":"Chlorproguanil\u2013dapsone\u2013artesunate versus chlorproguanil\u2013dapsone: a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated plasmodium falciparum malaria","volume":"81","author":"Tiono","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"9424","key":"10.1016\/j.japh.2025.103009_bib14","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(04)16350-2","article-title":"Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial","volume":"363","author":"Alloueche","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.japh.2025.103009_bib15","first-page":"536","article-title":"Influence of rifampicin on hydroxychloroquine","volume":"13","author":"Harvey","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.japh.2025.103009_bib16","first-page":"151","article-title":"Drug interaction during multidrug regimens for treatment of leprosy","volume":"87","author":"George","year":"1988","journal-title":"Indian J Med Res"},{"issue":"1","key":"10.1016\/j.japh.2025.103009_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF01061421","article-title":"Influence of once-monthly rifampicin and daily clofazimine on the pharmacokinetics of dapsone in leprosy patients in Nigeria","volume":"34","author":"Pieters","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.japh.2025.103009_bib18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0009-9236(95)90176-0","article-title":"Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo","volume":"58","author":"Mitra","year":"1995","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.japh.2025.103009_bib19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0022-3565(24)37079-X","article-title":"Comparison of the metabolism and toxicity of dapsone in rat, mouse and man","volume":"283","author":"Tingle","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"10.1016\/j.japh.2025.103009_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003252","article-title":"COVID-19 prevention and treatment: a critical analysis of chloroquine and hydroxychloroquine clinical pharmacology","volume":"17","author":"White","year":"2020","journal-title":"PLOS Med"},{"key":"10.1016\/j.japh.2025.103009_bib21","series-title":"Plaquenil (Hydroxychloroquine) [product labeling]","year":"2024"},{"issue":"2","key":"10.1016\/j.japh.2025.103009_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.japh.2025.103009_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/acr.24495","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis, and treatment of Lyme disease","volume":"73","author":"Lantos","year":"2021","journal-title":"Arthritis Care Res"},{"issue":"32","key":"10.1016\/j.japh.2025.103009_bib24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.15585\/mmwr.mm6832a4","article-title":"Updated CDC recommendation for serologic diagnosis of Lyme disease","volume":"68","author":"Mead","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"23","key":"10.1016\/j.japh.2025.103009_bib25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.15585\/mmwr.mm6623a3","article-title":"Serious bacterial infections acquired during treatment of patients given a diagnosis of chronic Lyme disease \u2014 United States","volume":"66","author":"Marzec","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.japh.2025.103009_bib26","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1086\/318138","article-title":"Death from inappropriate therapy for Lyme disease","volume":"31","author":"Patel","year":"2000","journal-title":"Clin Infect Dis"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125006880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125006880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:31:25Z","timestamp":1776079885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319125006880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1544319125006880"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2025.103009","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methemoglobinemia induced by dapsone, hydroxychloroquine, and rifampin combination for post-treatment Lyme disease syndrome: A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2025.103009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103009"}}